424870 — ImmuneOncia therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for ImmuneOncia therapeutics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	25,957	11,326	23,438
Net Total Accounts Receivable
Net Total Receivables	302	8,239	592
Prepaid Expenses
Total Current Assets	26,636	19,863	26,506
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	892	495	649
Net Intangible Assets
Other Long Term Assets
Total Assets	33,795	26,195	33,146
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	67,650	6,493	4,259
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	67,987	6,771	4,730
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	-34,192	19,424	28,415
Total Liabilities & Shareholders' Equity	33,795	26,195	33,146
Total Common Shares Outstanding